CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $321,000 | -69.9% | 38,660 | -72.9% | 0.00% | -100.0% |
| Q3 2019 | $1,065,000 | -47.4% | 142,651 | -21.0% | 0.00% | -50.0% |
| Q2 2019 | $2,026,000 | -43.5% | 180,653 | -45.8% | 0.00% | -50.0% |
| Q1 2019 | $3,584,000 | -21.1% | 333,400 | +10.7% | 0.00% | -20.0% |
| Q4 2018 | $4,542,000 | -45.0% | 301,126 | -32.5% | 0.01% | -28.6% |
| Q3 2018 | $8,255,000 | +2.2% | 446,223 | +26.2% | 0.01% | -12.5% |
| Q2 2018 | $8,081,000 | +383.6% | 353,530 | +501.9% | 0.01% | +300.0% |
| Q1 2018 | $1,671,000 | +44.7% | 58,739 | +7.4% | 0.00% | +100.0% |
| Q4 2017 | $1,155,000 | +16.1% | 54,703 | -0.2% | 0.00% | 0.0% |
| Q3 2017 | $995,000 | – | 54,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |